Posted on February 12th, 2016 by msequeira
Yanis Boumber, MD, PhD, has opened the first of ten new lung cancer clinical trials. Called Neptune, the phase 3 clinical trial combines two new immunotherapy drugs. Dr. Boumber talks to Mike Jaxson, KSVP-FM, about the trial:
You must be logged-in to the site to post a comment.